A Clear Clinical
Advantage

A Clear Clinical Advantage

Early, Often & Sustained Mobilization

Critically ill patients benefit from early mobilization as it has been associated with increased muscle strength, shorter duration of mechanical ventilation, and reduced length of stay.

Proven, Non-Invasive Approach

The Guardian Patient Management System has been validated in clinical studies to improve clinical outcomes.

In a landmark randomized clinical trial,
Guardian demonstrated:

0 %

Reduced sacral region pressure injury⁶

0 %

Length of stay
reduction⁶

In an initial feasibility study
Guardian demonstrated:

0 %

Shortened time to healing for existing pressure injuries⁷

Real-world experience suggests a greater length of stay reduction for patients treated with the Guardian System.

By promoting perfusion, the Guardian System supports early and sustained mobility – key factors shown to accelerate ventilator weaning, shorten length of stay, and improve functional outcomes in hospitalized patients.^2,3

DEMONSTRATED IMPROVED TIME TO CHAIR & CHAIR DURATION^1,2

DECREASED INCIDENCE OF HOSPITAL-ACQUIRED PNEUMONIA^1,2

IMPROVED TIME TO VENTILATOR WEANING^1,2

See the Data for Yourself

Learn more about our 399-patient randomized controlled trial investigating adverse event prevention in high-risk acute care patients.

And see how Guardian played a key role in optimizing protection and management of critically ill, mechanically ventilated COVID-19 patients.

In addition to prevention, Guardian has also demonstrated significant improvement in healing trajectory for existing pressure injuries.